Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 May 2019 | Story Xolisa Mnukwa | Photo Rian Horn
South Campus residence
UFS Housing and Residence Affairs leads transformation for university culture to improve student experience and Accommodation

The University of the Free State (UFS) Department of Housing and Residence Affairs (HRA) wants to ensure quality and affordable accommodation on and off campus for UFS students through the ITP.

The development of the ITP at the UFS started in January 2017; areas of transformation were identified, of which HRA’s deliverables are as follows:

• A detailed ‘as-is’ study to understand the issues faced by students regarding on- and off-campus accommodation and quantification of the accommodation gap.
• Development of a strategy to create residences with an academic focus, and the full implications regarding numbers and costing.
• Setting of minimum transport and safety standards for students.
• Development of an approach to student accommodation that is affordable for the students and entails optimal cost to the university.
• A strategy for postgraduate, postdoctoral, and international students.
• Gender-inclusive housing.

Mr Quintin Koetaan, Senior Director of HRA, and President of ACUHO-I SAC, started a project to ensure that NSFAS-funded and other UFS students are afforded quality accommodation on and off campus. Mr Koetaan was also appointed by NSFAS to convert this into a national project. This project includes engagements with different role players such as municipalities, national and provincial officials, the Tourism Grading Council of South Africa, NSFAS, and private off-campus accommodation service providers.

The decision by the UFS to increase the percentage of first-time entering students living on campus, was welcomed by HRA, and is being implemented and managed to address HRA’s ITP deliverables.  As a result of the increased percentage, senior students would be moved to affordable, accredited off-campus accommodation, with available transportation.

HRA’s aim is to ensure that students experience the wholesomeness and joy of being a UFS student, by making provision for their diverse on- and off-campus needs.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept